Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT04507737
Other study ID # pending
Secondary ID
Status Not yet recruiting
Phase N/A
First received
Last updated
Start date June 2021
Est. completion date June 2026

Study information

Verified date April 2020
Source Nordsjaellands Hospital
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This will be an investigator initiated One-sided blinded Randomized Clinical Trial.

The study will examine the composition of the Rapid Response Team (RRT). the investigators will examine to see if a Critical Care Outreach Team (CCOT) consisting of an ICU-Nurse and a general ward physician and nurse are non-inferior to a Medical Emergency Team (MET) consisting of an ICU-Doctor and ICU Nurse as well as a general ward physician and nurse. The randomization will be done using an Analogue randomization sequence using sealed opaque envelopes with central randomization.The experimental intervention will be the CCOT. The statistical analyses will be done on the primary outcomes in the intention to treat population and on the secondary outcomes on an per-protocol basis exempting those with protocol violations.


Description:

Trial design This trial is an investigator initiated, multi-centre, locally Randomized, one-side blinded trial of Nurse attended vs. Doctor attended RRT.

Randomization The patient will be screened for enrollment prior to the RRT leaving the ICU. A 1:1 randomization will occur at the time of call. The randomization will be with allocation concealment using a centrally randomized sequence at all participating sites. Due to time constraints the investigators will be using an analogue randomization sequence with sealed opaque envelopes. The Randomization sequence will be generated by a person independent of the project using Statistical software (SPSS or other like software) with a binary outcome of 0 or 1, where 0 will equal the control group and 1 will equal the intervention group. An independent group will then package sealed opaque envelopes in coherence with the sequence generated (controls will have blue cards, while interventions will be marked red). The sealed envelopes will be delivered to the primary investigator who will carry the responsibility of distributing these to the participating sites. When a patient is included the nurse will draw an envelope, open it, and sign the card which has been taken out. The local investigator or his/her delegate must on a daily basis collect and register the signed cards.

Blinding The allocation group is to be blinded for the investigators. As it is near impossible to blind the intervention for the clinicians the randomized allocation will not be blinded for the clinicians.

Members of the management committee (MC) will therefore not be involved in the daily clinical decision makings of the included patients. The outcome assessment will be blinded (i.e. registry-based assessment of interventions, evaluations, mortality, outcome and activation reasons). The statistical analyses will be with masked intervention groups i.e. coded as X/Y. And there will be done two conclusions, one defining x as the experimental group, and one assuming the opposite. The Steering Committee will be presented with two abstracts that must be accepted prior to breaking the bond.

If at anytime the investigators find it needed to investigate the results an Data Monitoring and Security Committee (DMSC) the members of the DMSC will remain blinded unless they 1) request unblinding or 2) find that an interim analysis provides strong indication of one intervention being beneficial or harmful.

Participant timeline The investigators will strive to enroll all patients fulfilling the inclusion criteria. Patients will receive either the experimental intervention of an ICU-Nurse attending the RRT, or the control of a Nurse and Doctor from the ICU attending the RRT. They will be followed up 30 days after RRT-event as well as 90- days post randomization. If another RRT-event occurs, within the same admission and within 30 days, another randomization will be performed, however the patient will only be included in the mortality comparison from the first randomization. If another RRT-event occurs within a new admission and within 30-days, the patient will receive another randomization however the patient will only be included in the mortality comparison from the first randomization. If another RRT-event occurs within a new admission after 30 days post randomization, the patient will receive a new randomization and will also be included in the mortality analysis twice.

Trial interventions Experimental intervention To ensure no dropout of data only MET-events where a MET-record is entered in the Electronic Medical Record (EMR) will be included.

The experimental intervention will be a MET-event attended only by an Intensive Care Unit Nurse, the team being led by the ward physician who is also responsible for treatment, even if this doctor is a junior doctor. All departments will be required to have a ward-physician attending a T-event in the trial period.

The ICU-nurse will be required to fill out an entry regarding the MET-event in the patients EMR, where details regarding the call may be registered Control intervention The control intervention will be standardized MET with both ICU doctor and ICU Nurse attending the patient. The ICU doctor will be team leader and the ward physician will be responsible for treatment as always.

The ICU doctor will be required to fill out an entry regarding the MET-event in the patients EMR, where details regarding the call may be registered Data collection Method Data will be obtained from the participants hospital files and national/regional/hospital registers (source data as defined per site, region and country) and by participant survey / interview and entered in the web-based REDCap database by trial investigators or their delegates. For participants transferred from a trial site to a non-trial site, data related to the outcomes will be collected according to national practice i.e. investigator contact to the relevant site or health-care registers.

Baseline variables are:

- Age

- Sex

- Time and Date of admission to hospital

- If applicable Time and Date of admission to ICU

- Time and Date of discharge

- Ward of RRT event

- Specialty responsible for the patient

- Admission cause


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 1500
Est. completion date June 2026
Est. primary completion date June 2024
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Admitted to any general ward of the hospital AND

- Aged = 18 years AND

- In need of RRT attention

Exclusion Criteria:

- Age < 18

- Admitted to the delivery ward

- Admitted to any ward in the anesthetic department

- ICU

- High Dependency Unit

- Post Operation Department

- Operating Theatre

- Same Day Admissions - Surgery Ward

- Not admitted at the time of call

- Evaluation track in Emergency department (prior to being seen by a doctor)

- Out-Patient departments

- X-ray department

- Any patient who cannot be randomized at the time of call

Study Design


Intervention

Other:
Rapid Response Team Composition_ ICU Nurse
In case of deterioration a Rapid Response Team may be activated. We will be examining the composition of the teams alternating between a MET or a CCOT.

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Nordsjaellands Hospital

Outcome

Type Measure Description Time frame Safety issue
Other Activation reason Exploratory outcome regarding the reason for activating the MET Through intervention completion, an average of 45 minutes
Other Interventions done by the RRT Exploratory outcome regarding the interventions done by the RRT Through intervention completion, an average of 45 minutes
Other Outcomes from the RRT -event Exploratory outcome regarding the outcomes when the RRT-event is ending. Through intervention completion, an average of 45 minutes
Other Evaluations by the RRT Exploratory outcome regarding the evaluations done by the RRT Through intervention completion, an average of 45 minutes
Primary 30-Day Mortality Binary outcome measured via the patient Electronic Medical Records up to 30 days
Primary In-Hospital Cardiac Arrest (IHCA) Binary outcome measured via the patient Electronic Medical Records: defined as any IHCA post randomization and until discharge or 30 days post randomization up to 30 days
Primary Unplanned Admission to the Intensive Care Unit Binary outcome measured via the patient Electronic Medical Records. Defined as Admission to the ICU more than 24h Post randomization until discharge or 30 day post randomization up to 30 days
Primary Unexpected Death Binary outcome measured via the Patient Electronic Medical Records and National Register of deaths in the population. Defined as Any deaths post randomization until discharge or 30 days post randomization without treatment limitation being implemented during or 24 hours after the RRT, and without a "do not attempt resuscitation" order up to 30 days
Secondary Activation of escape protocol Besides a few defined criteria the nurse may at any time activate the escape protocol and summon the ICU doctor to the patient immediately. If this is done at any time, it will be logged in the Electronic Medical Records and subsequently registered in the eCRF Through intervention completion, an average of 45 minutes
Secondary 90-day mortality Binary outcome measured via the Patient electronic medical records. 90 days
Secondary Time Spent Bedside Continuous outcome measured via the Patient Electronic medical records - the MET-note. Defined in Minutes Through intervention completion, an average of 45 minutes
Secondary Initiation of End of Life Care (EOL) Binary outcome measured via the Patient Electronic Medical Records, defined as any treatment limitations involving cessation of all treatment, prescription of a safety/comfort package, No increase in treatment level - no ICU involvement and no MET involvement. Maximum 30 days post randomization
Secondary Score To Door Time Continuous outcome calculated via the Patient Electronic medical records the MET-note, defined as the time from activation of the RRT until arrival at the ICU. Through intervention completion, an average of 4 hours
Secondary Survival until discharge Binary outcome measured via the patient Electronic Medical Records From date of admission until the date discharged up to 1 year.
Secondary Length of Stay Continuous outcome measured via the Patient Electronic Medical records defined in Days, measured from admission date till discharge or death date. From date of admission until discharged up to 1 year
See also
  Status Clinical Trial Phase
Not yet recruiting NCT05465187 - Withholding or Withdrawing of Life-sustaining Therapy in Great East French Region Intensive Care Units: a 1-month Survey
Active, not recruiting NCT04476355 - Implementation of Physical Restraints Clinical Practice Guidelines for Critically Ill Patients Using the CAN-IMPLEMENT Framework N/A
Completed NCT05038514 - The Effect of Music Therapy in COVID-19 Patients Given Prone Position N/A
Completed NCT03355625 - Platelet Function During Extracorporeal Membrane Oxygenation in Adult Patients
Completed NCT02819154 - Study of the Social and Psychological Consequences of ICU Hospitalization N/A
Completed NCT02995811 - Characterising Changes in Muscle Quantity and Quality in Patients Requiring ECMO Oxygen During Critical Illness
Completed NCT03335527 - Impacts of Low-Dose Dexmedetomidine on Sleep Quality in Mechanically Ventilated ICU Patients Phase 4
Completed NCT03401411 - ICU Triage Practices in a Cancer Hospital N/A
Recruiting NCT06046690 - Comparison Of The Effects Of Inspiratory Muscle Training Methods in Mechanically Ventilated Patients N/A
Not yet recruiting NCT05960994 - Evaluation of the Clinical Impact of Different Telemedicine Practices in Intensive Care Units N/A
Completed NCT04372056 - The COVID-ICU Healthcare Professional Study
Completed NCT03545776 - Critical Care EEG Course
Completed NCT03180203 - Postoperative INTELLiVENT-ASV Ventilation N/A
Terminated NCT02101762 - Study to Compare CAUTI Rates Following ERASE CAUTI Tray Non-Silver vs Silver Coated Foley Catheters N/A
Completed NCT05874531 - End-expiratory Occlusion Test and Prediction of Preload Dependence
Not yet recruiting NCT04872881 - Comparison of Effectiveness of Different Airway Management Methods During Percutaneous Tracheostomy Phase 4
Completed NCT04664101 - REmotely Monitored, Mobile Health-Supported High Intensity Interval Training After COVID-19 Critical Illness (REMM-HIIT-COVID-19) N/A
Completed NCT02040051 - Efficacy of Sound Insulation and Music Therapy on the Comfort of Mechanically Ventilated Patients Admitted to Intensive Care Unit N/A
Completed NCT01235637 - Alfentanil Versus Sufentanil for Pain in Children During for Tracheal Suction Phase 3
Recruiting NCT05660252 - Effect of Collaborative Requesting on DCD Refusal Rates: Randomized Controlled Trial N/A